Chemed (CHE) Up 2.7% Since Last Earnings Report: Can It Continue?

Core Viewpoint - Chemed's shares have increased by approximately 2.7% since the last earnings report, underperforming the S&P 500, raising questions about the sustainability of this trend leading up to the next earnings release [1] Earnings Estimates - Analysts have not made any earnings estimate revisions in the past two months, indicating a period of quiet regarding expectations for the company's performance [2] VGM Scores - Chemed has a strong Growth Score of A, a Momentum Score of B, and a Value Score of D, placing it in the bottom 40% for value investment strategy. The overall aggregate VGM Score is B, which is relevant for investors not focused on a single strategy [3] Outlook - Chemed holds a Zacks Rank of 4 (Sell), suggesting expectations for below-average returns in the upcoming months [4]